Present and future of cancer immunotherapy: A tumor microenvironmental perspective

Oncology Letters
Yu Yu, Jiuwei Cui

Abstract

Modulation of the tumor microenvironment is becoming an increasingly popular research topic in the field of immunotherapy, and studies regarding immune checkpoint blockades and cancer immunotherapy have pushed cancer immunotherapy to a climax. Simultaneously, the manipulation of the immune regulatory pathway can create an effective immunotherapy strategy; however, the tumor microenvironment serves an important role in suppressing the antitumor immunity by its significant heterogeneity. A number of patients with cancer do not have a good response to monotherapy approaches; therefore, combination strategies are required to achieve optimal therapeutic benefits. Targeting the tumor microenvironment may provide a novel strategy for immunotherapy, break down the resistance of conventional cancer therapy and produce the foundation for personalized precision medicine. The present review summarized the research regarding cancer immunotherapy from the perspective of how the tumor microenvironment affects the immune response, with the aim of proposing a novel strategy for cancer immunotherapy and combination therapy.

References

Sep 17, 2002·Cell Death and Differentiation·F FallarinoP Puccetti
Feb 20, 2004·Nature·Timothy P PaderaRakesh K Jain
Jun 14, 2005·The Journal of Clinical Investigation·Satoshi KashiwagiDai Fukumura
Mar 31, 2006·Nature Reviews. Cancer·Raghu Kalluri, Michael Zeisberg
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Oct 28, 2009·Seminars in Cell & Developmental Biology·Masayuki ShimodaAkira Orimo
Mar 7, 1927·The Journal of General Physiology·O WarburgE Negelein
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
May 20, 2011·Nature·Peter Carmeliet, Rakesh K Jain
Jul 9, 2011·Nature Immunology·E John Wherry
Jul 12, 2011·Physiological Reviews·Shom GoelRakesh K Jain
Sep 24, 2011·Nature Reviews. Immunology·Gregory T Motz, George Coukos
Mar 15, 2012·Cancer Research·Melody A SwartzYves A DeClerck
Aug 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christine FeigDavid A Tuveson
Oct 30, 2012·Trends in Immunology·David H Munn, Andrew L Mellor
Mar 9, 2013·Nature Reviews. Immunology·Lieping Chen, Dallas B Flies
Mar 27, 2013·BMB Reports·Ainhoa Mielgo, Michael C Schmid
May 15, 2013·Cancer Immunology, Immunotherapy : CII·Jürgen C BeckerPer Thor Straten
May 15, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rakesh K Jain
Jun 5, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sunitha KakarlaStephen Gottschalk
Jun 28, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B MelicharUNKNOWN BEVLiN Investigators
Jul 19, 2013·The Journal of Clinical Investigation·Anusha KalbasiNeha Vapiwala
Sep 21, 2013·Nature·Melissa R Junttila, Frederic J de Sauvage
Nov 10, 2013·Nature Medicine·Daniela F Quail, Johanna A Joyce
Dec 4, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian I RiniBernard Escudier
Jan 18, 2014·International Journal of Molecular Sciences·Bonggoo ParkKyung-Mi Lee
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Mar 8, 2014·World Journal of Gastroenterology : WJG·Agnieszka Anna Rucki, Lei Zheng
Aug 15, 2014·Neoplasia : an International Journal for Oncology Research·Einar K RofstadBerit S Mathiesen
Dec 17, 2014·Expert Opinion on Investigational Drugs·Anasuya Gunturi, David F McDermott
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory L Beatty, Whitney L Gladney
Dec 30, 2014·Trends in Cell Biology·Florian Klemm, Johanna A Joyce
Mar 19, 2015·International Journal of Cancer. Journal International Du Cancer·Kuppusamy Balamurugan
Mar 26, 2015·Immunotherapy·Angus G Dalgleish

❮ Previous
Next ❯

Citations

Dec 7, 2018·International Journal of Molecular Sciences·Suchithra Poilil SurendranYong Yeon Jeong
Feb 6, 2019·International Journal of Molecular Sciences·Stephan Niland, Johannes A Eble
Feb 9, 2020·Journal for Immunotherapy of Cancer·Samuel Chuah, Valerie Chew
May 8, 2020·Cancer Immunology, Immunotherapy : CII·Jasna MetovicMauro Papotti
Jul 25, 2019·Current Pharmaceutical Design·Omar H A Al-AttraqchiNoor H A Al-Attraqchi
Aug 31, 2019·Oxidative Medicine and Cellular Longevity·Anastasiya V SnezhkinaAlexey A Dmitriev
Jul 3, 2019·International Journal of Molecular Sciences·Magdalena Jarosz-BiejNatalia Kułach
Feb 11, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Spyridon A KalospyrosAlexandros G Georgakilas
May 18, 2021·Frontiers in Molecular Biosciences·Sharia HernandezEdwin Roger Parra
May 15, 2020·Molecular Pharmaceutics·Da Hye KimKun Na
Oct 13, 2019·Current Medicinal Chemistry·Zakia AkterMd Asaduzzaman Khan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.